Germany’s Merck KGaA has agreed to buy SpringWorks Therapeutics, adding the US biotech’s portfolio of cancer and rare disease ...

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

Recent developments in health highlight key agreements between countries, drug approvals, corporate revenue growth, and ...

The Hormone Replacement Therapy Market is estimated to grow at a CAGR of 6.48% during the forecast period from 2024 to 2030.

The health sector is abuzz with significant news: from FDA approvals of novel drugs and mergers like Merck's acquisition of ...

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily ...

Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

Biopharmaceutical giant Merck (NYSE: MRK) has broken ground on a $1 billion pharmaceutical manufacturing facility in Wilmington, about 30 miles southwest of Philadelphia. Known as Merck Wilmington ...

Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction ...

According to SNS Insider Report, The Rising Demand for Biologics and Cell Therapy Drives Accelerated Growth in the Mycoplasma Testing Market.Austin, May 01, 2025 (GLOBE NEWSWIRE) -- Mycoplasma Testing ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.